Capital World Investors
Position in CRL — Charles River Laboratories International, Inc.
CIK 1422849
LOS ANGELES, CA
Position in CRL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,183,904
+$1,778,202 QoQ
Shares Held
14,039
+72.3% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#159
of 569 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Capital World Investors holds $6,483,252,498 across 6 Diagnostics & Research names. CRL ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,195,370 | $3,106,110,703 | |
| 2 | ILMN |
Illumina, Inc.
|
15,425,298 | $2,712,230,147 | |
| 3 | NTRA |
Natera, Inc.
|
1,504,387 | $408,365,851 | |
| 4 | ICLR |
Icon PLC
|
1,106,056 | $192,132,987 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
316,887 | $61,228,906 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
This page
|
14,039 | $3,183,904 |
All Filings in CRL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,183,904 | 14,039 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,405,702 | 8,149 | Shares | Defined | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||